CCM
ACAD icon

Convector Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Convector Capital Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$541K Sell
17,000
-10,300
-38% -$349K 0.99% 27
2016
Q2 		$886K Sell
27,300
-33,700
-55% -$1.13M 1.22% 25
2016
Q1 		$1.71M Buy
61,000
+42,000
+221% +$916K 1.73% 22
2015
Q4 		$677K Buy
+19,000
New +$669K 0.64% 32

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Convector Capital Management's ACAD Position: Q3 2016 in Review

Convector Capital Management reduced its Acadia Pharmaceuticals (ACAD) stake by 38% in Q3 2016, selling an estimated $349K and leaving 17,000 shares worth $541K. The position accounts for 0.99% of the portfolio, ranked #27.

Convector Capital Management first reported a position in ACAD in Q4 2015 and has held it in 4 quarters since. The position peaked at $1.71M in Q1 2016. 232 funds tracked by Wall St. Rank hold ACAD as of Q3 2016.

  • Convector Capital Management held 17,000 shares of Acadia Pharmaceuticals worth $541K as of Q3 2016.
  • Convector Capital Management sold 10,300 Acadia Pharmaceuticals shares in Q3 2016, an estimated $349K.
  • Acadia Pharmaceuticals made up 0.99% of Convector Capital Management's portfolio in Q3 2016, its #27 holding.
  • Convector Capital Management first reported a position in Acadia Pharmaceuticals in Q4 2015 and has held it in 4 quarters since.
  • Convector Capital Management's Acadia Pharmaceuticals position peaked at $1.71M in Q1 2016.
  • 232 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2016.

Based on Convector Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.